Neuropeptide Y and the Calcitonin Gene‐related Peptide Attenuate Learning Impairments Induced by MK‐801 via a Sigma Receptor‐related mechanism

Authors:

Abstract
It has been shown recently that low doses of sigma (σ) receptor ligands like 1,3‐di‐(2‐tolyl)guanidine (DTG), (+)N‐allylnormetazocine [(+)SKF 10 047] and (+)pentazocine can antagonize learning impairments induced by dizocilpine (MK‐801), a non‐competitive antagonist at the NMDA receptor channel. This antagonism has been proposed to involve σ receptor sites since it is blocked by the administration of purported o antagonists such as NE‐100 and BMY‐14802. It has also been demonstrated that peptides of the neuropeptide Y (NPY) and calcitonin gene‐related peptide (CGRP) families modulate, in vivo, é labelling and electrophysiological effects in the hippocampal formation. Accordingly, we investigated if NPY‐ and CGRP‐related peptides modulate cognitive processes by interacting with σ sites in mice. In order to test this hypothesis, a step‐down passive avoidance task was used. Interestingly, similarly to various σ agonists, NPY, peptide YY (PYY) and the Y1 agonist [Leu31Pro34]NPY (but not NPY13–36, a purported Y2 agonist), as well as hCGRPα and the purported CGRP2 agonist [CyS(ACM)2–7]hCGRPα (but not CGRP8–37, a CGRP1 receptor antagonist), significantly attenuated learning impairments induced by MK‐801. Furthermore, the effects of NPY, [Leu31 Pro34]NPY, hCGRPα and [CYS(ACM)2–7]hCGRPα were blocked by the administration of the σ antagonist, BMY‐14802. The present data suggest that NPY‐ and CGRP‐related peptides can indirectly interact in vivo with σ receptors to modulate cognitive processes associated with NMDA receptor function.

This publication has 36 references indexed in Scilit: